With nearly €80 billion in funding allocated for over the next seven years, Horizon 2020 is the EU’s largest research and innovation initiative. By taking great ideas from the lab to the market, this program promises many breakthroughs, which are intended to enhance Europe’s global competitiveness. Established as a means of driving economic growth and creating jobs, Horizon2020 will make it easier for public and private sectors to work together to push the frontiers of innovation.
The program focuses on three overarching priorities: excellent science, industrial leadership, and solutions to global challenges. Horizon 2020 recognizes the importance of internationalizing how knowledge is produced and is thus open to participants from anywhere in the world. On Wednesday, March 12, 2014, please join panelists from both sides of the Atlantic to hear their testimonials and to learn about the different types of international cooperation that Horizon 2020 supports, namely on an individual, collaborative, or program level. The presentations will also address in detail the main elements of Horizon 2020 with regards to content, types of activities funded, forms of participation, and application procedures.
Dr. James P. Gavigan, Minister Counselor and Head of the Research and Innovation Section of the Delegation of the European Union to the United States of America, will provide an overview of the Horizon2020 program. In addition to liaising between the EU and the US on policy-driven cooperation in research and innovation, Dr. Gavigan is also responsible for facilitating cooperation between US-based EU Member State Science Counselors, undertaking outreach and promotional activities, and fulfilling regular Counselor duties.
He will be joined by Dr. Paolo Boffetta, Director of the Institute for Translational Epidemiology and Associate Director for Population Sciences at The Tisch Cancer Center at Mount Sinai School of Medicine. Dr. Boffetta formerly headed the Division of Clinical Epidemiology at the German Cancer Research Center in Heidelberg, Germany. Dr. Boffetta will provide a testimonial on the benefits of transatlantic cooperation, drawing upon his personal experience as a partner in the EU-funded project CHANCES (Consortium on Health and Ageing: Network Cohorts in Europe and the United States).
Dr. Brian Gibney, Jacques Edward Levy Professor of Analytical Chemistry at Brooklyn College of The City University of New York, will similarly discuss his experience as a partner in the EU-funded project PEPDIODE, which focuses on peptide-based diode screening for solar cells. The project is a joint research effort between six international partners, including the Karlsruhe Institute of Technology (KIT) in Germany. Dr. Gibney is currently the Deputy Executive Officer of the CUNY Ph.D. Program in Chemistry. His research interests are in bioinorganic chemistry, protein design, and photosynthesis.
Dr. Joann Halpern, Director of the German Center for Research and Innovation, will discuss Germany’s participation in Horizon2020 during her introductory remarks and will also moderate the discussion.
The event will take place on Wednesday, March 12, from 6:30 to 8:30 p.m., at the German Center for Research and Innovation (871 United Nations Plaza, First Avenue, btw. 48th & 49th Streets).
Unable to attend? Follow @gcri_ny and the hashtag #H2020 for live tweets.
Media Contact:
Jennifer Audet
Tel.: (212) 339 8680, ext. 302
E-Mail: Audet(at)GermanInnovation.org
Further Information:
This event is co-sponsored by the German Center for Research and Innovation (GCRI) and the Delegation of the European Union to the U.S.
The German Center for Research and Innovation provides information and support for the realization of cooperative and collaborative projects between North America and Germany. With the goal of enhancing communication on the critical challenges of the 21st century, GCRI hosts a wide range of events from lectures and exhibitions to workshops and science dinners. Opened in February 2010, GCRI was created as a cornerstone of the German government’s initiative to internationalize science and research and is one of five centers worldwide.
